Lepu Medical Technology (Beijing) 관리

관리 기준 확인 4/4

Lepu Medical Technology (Beijing) CEO는 Zhi Bin Zhang, Sep2015 에 임명되었습니다 의 임기는 9.17 년입니다. 는 CN¥ 2.56M 가치에 해당하는 회사 주식의 0.012% 직접 소유합니다. 2.56M. 경영진과 이사회의 평균 재임 기간은 각각 11.8 년과 4.8 년입니다.

주요 정보

Zhi Bin Zhang

최고 경영자

CN¥2.0m

총 보상

CEO 급여 비율	n/a
CEO 임기	9.2yrs
CEO 소유권	0.01%
경영진 평균 재임 기간	11.8yrs
이사회 평균 재임 기간	4.8yrs

최근 관리 업데이트

Recent updates

CEO

Zhi Bin Zhang (48 yo)

9.2yrs

테뉴어

CN¥1,953,800

보상

Mr. Zhang Zhi Bin serves as General Manager of Lepu Medical Technology (Beijing) Co., Ltd. since September 10, 2015 and also served as its Deputy General Manager. Mr. Zhang served as General Manager of Sha...

리더십 팀

이름	위치	테뉴어	보상	소유권
Zhongjie Pu	Chairman & CTO	16.9yrs	데이터 없음	12.37% CN¥ 2.7b
Zhi Bin Zhang	General Manager	9.2yrs	CN¥1.95m	0.012% CN¥ 2.6m
Yong Wang	Senior Deputy GM & CFO	17.7yrs	CN¥1.70m	0.010% CN¥ 2.3m
Zhan Jiang Wei	Senior Deputy General Manager	21.8yrs	CN¥1.70m	0.011% CN¥ 2.3m
Xia Zhang	Senior Deputy General Manager	11.8yrs	CN¥400.00k	데이터 없음
Weina Jiang	Secretary of the Board of Directors	3.3yrs	CN¥1.44m	데이터 없음
Bing Feng Zhang	Deputy General Manager	no data	CN¥1.53m	데이터 없음
Guorui Zheng	Deputy General Manager	3.6yrs	CN¥1.25m	0.0016% CN¥ 353.4k

11.8yrs

평균 재임 기간

49.5yo

평균 연령

경험이 풍부한 관리: 300003 의 관리팀은 노련하고 경험 (평균 재직 기간 11.8 년)입니다.

이사회 구성원

이름	위치	테뉴어	보상	소유권
Zhongjie Pu	Chairman & CTO	16.9yrs	데이터 없음	12.37% CN¥ 2.7b
Yang Xu	Non Independent Director	10.8yrs	CN¥300.00k	데이터 없음
Fei Pu	Non Independent Director	4.8yrs	CN¥874.10k	데이터 없음
Liang Gan	Independent Director	4.8yrs	CN¥300.00k	데이터 없음
Xinglin Wang	Chairman of the Supervisory Board	4.8yrs	데이터 없음	데이터 없음
Jun Wang	Non Employee Supervisor	4.8yrs	데이터 없음	데이터 없음
Lihua Wang	Independent Director	4.6yrs	CN¥300.00k	데이터 없음
Qihong Wang	Non-Independent Vice Chairman	3.7yrs	데이터 없음	데이터 없음
Ming Yang	Employee Supervisor	7.3yrs	데이터 없음	데이터 없음
Xin Qu	Independent Director	1.5yrs	CN¥300.00k	데이터 없음

4.8yrs

평균 재임 기간

58.5yo

평균 연령

경험이 풍부한 이사회: 300003 의 이사회는 경험(평균 재직 기간 4.8 년)으로 간주됩니다.

Lepu Medical Technology (Beijing) 관리

관리 기준 확인 4/4

주요 정보

최근 관리 업데이트

Lepu Medical Technology (Beijing) Co., Ltd., Annual General Meeting, May 15, 2024

Lepu Medical Technology (Beijing) Co., Ltd. Approves the Election of Wang Qihong as Non-Independent Director and Qu Xin as Independent Director

Insufficient new directors

Recent updates

Third quarter 2024 earnings released: EPS: CN¥0.057 (vs CN¥0.21 in 3Q 2023)

Investor sentiment deteriorates as stock falls 21%

New minor risk - Share price stability

Lepu Medical Technology (Beijing) Co., Ltd. to Report Q3, 2024 Results on Oct 26, 2024

Investor sentiment improves as stock rises 24%

Lepu Medical Technology (Beijing) Co., Ltd. Approves Interim Cash Dividend on A Shares for the 2024, Payable on 20 September 2024

Lepu Medical Technology (Beijing) Co., Ltd. Approves 2024 Interim Profit Cash Dividend (Tax Included)

Second quarter 2024 earnings released: EPS: CN¥0.12 (vs CN¥0.20 in 2Q 2023)

Lepu Medical Technology (Beijing) Co., Ltd. to Report First Half, 2024 Results on Aug 24, 2024

Dividend reduced to CN¥0.33

Lepu Medical Technology (Beijing) Co., Ltd. Implements 2023 Final Profit Distribution for A Shares, Payable on 27 June 2024

Lepu Medical Technology (Beijing) Co., Ltd., Annual General Meeting, May 15, 2024

First quarter 2024 earnings released: EPS: CN¥0.26 (vs CN¥0.32 in 1Q 2023)

Lepu Medical Technology (Beijing) Co., Ltd. to Report Q1, 2024 Results on Apr 20, 2024

Investor sentiment improves as stock rises 15%

Lepu Medical Technology (Beijing) Co., Ltd. to Report Fiscal Year 2023 Results on Apr 20, 2024

Lepu Medical Technology (Beijing) Co., Ltd. (SZSE:300003) announces an Equity Buyback for CNY 500 million worth of its shares.

Lepu Medical Technology (Beijing) Co., Ltd. (SZSE:300003) announces an Equity Buyback for CNY 500 million worth of its shares.

Investor sentiment improves as stock rises 16%

Lepu Medical Technology (Beijing) Co., Ltd. to Report Q3, 2023 Results on Oct 26, 2023

Second quarter 2023 earnings released: EPS: CN¥0.20 (vs CN¥0.41 in 2Q 2022)

Lepu Medical Technology (Beijing) Co., Ltd. Announces Final Profit Distribution for 2022, Payable on 30 June 2023

Lepu Medical Technology (Beijing) Co., Ltd. Approves the Election of Wang Qihong as Non-Independent Director and Qu Xin as Independent Director

First quarter 2023 earnings released: EPS: CN¥0.32 (vs CN¥0.30 in 1Q 2022)

Insufficient new directors

Third quarter 2022 earnings released: EPS: CN¥0.30 (vs CN¥0.11 in 3Q 2021)

Investor sentiment improved over the past week

Lepu Medical Technology (Beijing) Co., Ltd. has completed a Follow-on Equity Offering in the amount of $224.238141 million.

Second quarter 2022 earnings released: EPS: CN¥0.41 (vs CN¥0.56 in 2Q 2021)

Lepu Medical Technology (Beijing) Co., Ltd. Announces Final Profit Distribution on Share A for 2021, Payable on June 30, 2022

Lepu Medical Technology (Beijing) Co., Ltd. Approves Cash Dividend for the Year 2021

Lepu Medical Technology (Beijing) Co., Ltd. Proposes Dividend for 2021

First quarter 2022 earnings released: EPS: CN¥0.30 (vs CN¥0.41 in 1Q 2021)

Now 20% undervalued after recent price drop

Now 22% undervalued after recent price drop

Now 22% undervalued after recent price drop

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Second quarter 2021 earnings released: EPS CN¥0.56 (vs CN¥0.43 in 2Q 2020)

Lepu Medical Technology (Beijing) Co., Ltd. Approves Cash Dividend for the Year 2020

First quarter 2021 earnings released: EPS CN¥0.41 (vs CN¥0.22 in 1Q 2020)

Lepu Medical Technology (Beijing) Co., Ltd. Proposes Cash Dividend for the Year 2020

Full year 2020 earnings released: EPS CN¥1.07 (vs CN¥0.97 in FY 2019)

Lepu Medical Technology (Beijing) Co., Ltd. to Report Fiscal Year 2020 Results on Mar 31, 2021

Investor sentiment improved over the past week

New 90-day high: CN¥32.23

New 90-day low: CN¥27.72

New 90-day low: CN¥29.09

Third quarter earnings released

New 90-day low: CN¥31.28

New 90-day low - CN¥34.56

First half earnings released

CEO

테뉴어

보상

리더십 팀

평균 재임 기간

평균 연령

이사회 구성원

평균 재임 기간

평균 연령